(Q44147443)

English

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.

scientific article published on 3 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. (English)

1 reference

Europe PubMed Central

30 November 2017

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

Egeruan B Imoukhuede

7

1 reference

Europe PubMed Central

30 November 2017

Thomas L. Richie

12

1 reference

Europe PubMed Central

30 November 2017

10

object named as

K Marsh

1 reference

Europe PubMed Central

30 November 2017

Christian F Ockenhouse

11

object named as

C F Ockenhouse

1 reference

Europe PubMed Central

30 November 2017

author name string

V S Moorthy

1

1 reference

Europe PubMed Central

30 November 2017

C Diggs

2

1 reference

Europe PubMed Central

30 November 2017

S Ferro

3

1 reference

Europe PubMed Central

30 November 2017

M F Good

4

1 reference

Europe PubMed Central

30 November 2017

S Herrera

5

1 reference

Europe PubMed Central

30 November 2017

A V Hill

6

1 reference

Europe PubMed Central

30 November 2017

S Kumar

8

1 reference

Europe PubMed Central

30 November 2017

C Loucq

9

1 reference

Europe PubMed Central

30 November 2017

R W Sauerwein

13

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

3 August 2009

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

27

1 reference

Europe PubMed Central

30 November 2017

42

1 reference

Europe PubMed Central

30 November 2017

5719-5725

1 reference

Europe PubMed Central

30 November 2017

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Plasmodium falciparum malaria vaccines in development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Asexual blood-stage malaria vaccine development: facing the challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Malaria transmitted to humans by mosquitoes infected from cultured plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Detection and identification of human Plasmodium species with real-time quantitative nucleic acid sequence-based amplification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.049

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.07.049

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44147443&oldid=2107135067"